tiprankstipranks

Analyst Profile

Followed by 17,210 followers
.
Ram Selvaraju

Ram Selvaraju

H.C. Wainwright
Wall Street Analyst
#7,820 out of 7,963 Wall Street Analysts
#21,760 out of 22,261 experts

Success Rate

14%
55 out of 403 transactions made a profit

Average Return

-36.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Ram Selvaraju's trades since 2009 and holding each position for 1 Year would result in 13.65% of your transactions generating a profit, with an average return of -36.1% per rating.

Stock Rating Distribution

3KRatings
93.70% Buy
6.05% Hold
0.24% Sell
Distribution of Ram Selvaraju's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
United KingdomUK Market

Best Rating

Stock:
Axsome Therapeutics Inc.
(AXSM)
Rating:Buy
Date:Aug 30, 2021 - Aug 30, 2022
Return:+151.10%
The most profitable rating made by Ram Selvaraju

Ram Selvaraju's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
SQNM
Sequenom
Sep 30, 2009
Sell
Downgraded
1Ratings
0.00%
XNPT
XenoPort
Feb 18, 2010
Sell
Downgraded
1Ratings
0.00%
GENZ
Genzyme
Apr 21, 2010
Hold
Upgraded
1Ratings
0.00%
SELLAS Life Sciences Group
Nov 28, 2012
Buy
Initiated
$6.00
(172.73% Upside)
1Ratings
0.00%
TSRX
Trius Therap
Jul 31, 2013
Hold
Downgraded
2Ratings
0.00%
Riot Blockchain
Aug 19, 2013
Buy
Reiterated
$28.00
(281.47% Upside)
1Ratings
0.00%
Rosetta Genomics
Oct 30, 2013
Hold
Downgraded
$3.50
(3499900.00% Upside)
1Ratings
0.00%
Sinovac Biotech
Nov 13, 2013
Buy
Reiterated
3Ratings
0.00%
Global Cord Blood
Feb 25, 2014
Buy
Reiterated
$7.00
(134.30% Upside)
1Ratings
0.00%
Navidea
Mar 06, 2014
Hold
Reiterated
$2.50
(917.92% Upside)
2Ratings
0.00%
List of latest recommendations made by Ram Selvaraju. Click to expand and see Ram Selvaraju's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >